Preethi Sundaram - Dec 8, 2023 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Strategy Officer
Signature
/s/ Preethi Sundaram
Stock symbol
CPRX
Transactions as of
Dec 8, 2023
Transactions value $
$0
Form type
4
Date filed
12/12/2023, 05:00 PM
Previous filing
Feb 17, 2023
Next filing
Dec 29, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Award $0 +143K +34.6% $0.00 557K Dec 8, 2023 Common Stock 143K $14.15 Direct F1
transaction CPRX Restricted Stock Units Award $0 +20.6K +3.69% $0.00 578K Dec 8, 2023 Common Stock 20.6K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Derivative securities vest in equal tranches, 1/3rd on December 8, 2024, 1/3rd on December 8, 2025 and 1/3rd on December 8, 2026.
F2 Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
F3 Shares of common stock will be delivered to the Reporting Person upon vesting.